Posted: 22 June 2017 |
Head of Drug Discovery at the Fraunhofer Institute for Molecular Biology and Applied Ecology
Dr Sheraz Gul is Head of Drug Discovery at the Fraunhofer Institute for Molecular Biology and Applied Ecology. He is responsible for the management and development of assay development and medium and high throughput screening activities for partners across the world. He has 23 years’ experience in both academia (University of London) and industry (GlaxoSmithKline Pharmaceuticals). This has ranged from the detailed study of catalysis by biological catalysts (enzymes and catalytic antibodies) to the design and development of assays for high throughput screening for the major drug target classes. He is the co-author of numerous papers, chapters and the ‘Enzyme Assays: Essential Data’ handbook.